Top-News

Albany Molecular Research News

Keine aktuellen Kursdaten verfügbar
WKN: 918849
ISIN: US0124231095
Typ: Aktie

Albany Molecular Research News

17.08.17 - PR Newswire
Control4 Set to Join S&P SmallCap 600
Control4 Set to Join S&P SmallCap 600 PR Newswire
13.07.17 - PR Newswire
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Albany Molecular Research, Inc. (AMRI)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Albany Molecular Research, Inc. (AMRI) PR Newswire
05.07.17 - PR Newswire
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Albany Molecular Research, Inc. - AMRI
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Albany Molecular Research, Inc. - AMRI PR Newswire
29.06.17 - PR Newswire
AMRI Announces Early Termination of HSR Waiting Period for The Carlyle Group and GTCR's Proposed Acquisition of AMRI
AMRI Announces Early Termination of HSR Waiting Period for The Carlyle Group and GTCR's Proposed Acquisition of AMRI PR Newswire
09.06.17 - PR Newswire
WeissLaw LLP: The Proposed Acquisition of Albany Molecular Research Inc. May Not Be In the Best Interest of AMRI Shareholders
WeissLaw LLP: The Proposed Acquisition of Albany Molecular Research Inc. May Not Be In the Best Interest of AMRI Shareholders PR Newswire
07.06.17 - PR Newswire
Harwood Feffer LLP Announces Investigation of Albany Molecular Research, Inc.
Harwood Feffer LLP Announces Investigation of Albany Molecular Research, Inc. PR Newswire
06.06.17 - PR Newswire
ALBANY MOLECULAR INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Albany Molecular Research, Inc.
ALBANY MOLECULAR INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed ...
06.06.17 - PR Newswire
Albany Molecular (AMRI) Alert: J&W Investigates Price and Process of Proposed Sale of Albany Molecular Research, Inc.; Is $21.75 a Fair Price?
Albany Molecular (AMRI) Alert: J&W Investigates Price and Process of Proposed Sale of Albany Molecular Research, Inc.; Is $21.75 a Fair Price? PR Newswire
06.06.17 - PR Newswire
AMRI Signs Definitive Agreement To Be Acquired By The Carlyle Group and GTCR for $21.75 per share in cash
AMRI Signs Definitive Agreement To Be Acquired By The Carlyle Group and GTCR for $21.75 per share in cash PR Newswire
06.06.17 - PR Newswire
AMRI Signs Definitive Agreement To Be Acquired By The Carlyle Group and GTCR for $21.75 per share in cash
AMRI Signs Definitive Agreement To Be Acquired By The Carlyle Group and GTCR for $21.75 per share in cash PR Newswire
02.06.17 - PR Newswire
AMRI to Present at Jefferies Healthcare Conference
AMRI to Present at Jefferies Healthcare Conference PR Newswire
09.05.17 - PR Newswire
AMRI Announces First Quarter 2017 Results
AMRI Announces First Quarter 2017 Results PR Newswire
09.05.17 - PR Newswire
AMRI Announces First Quarter 2017 Results
AMRI Announces First Quarter 2017 Results PR Newswire
02.05.17 - PR Newswire
AMRI Receives NIH Contract Award for Drug Substance Development and Manufacturing Services
AMRI Receives NIH Contract Award for Drug Substance Development and Manufacturing Services PR Newswire
26.04.17 - PR Newswire
SSCI Receives a 2017 Biotechnology Award for Global Research and Manufacturing
SSCI Receives a 2017 Biotechnology Award for Global Research and Manufacturing PR Newswire
25.04.17 - PR Newswire
AMRI Schedules First Quarter 2017 Earnings Release and Conference Call
AMRI Schedules First Quarter 2017 Earnings Release and Conference Call PR Newswire
24.04.17 - PR Newswire
Denovo Biopharma Obtains Exclusive License To Liafensine From AMRI
Denovo Biopharma Obtains Exclusive License To Liafensine From AMRI - Denovo Biopharma gains an exclusive license to all rights to develop, manufacture and commercialize ...
03.03.17 - PR Newswire
AMRI to Present at Barclays Global Healthcare Conference
AMRI to Present at Barclays Global Healthcare Conference PR Newswire
21.02.17 - PR Newswire
AMRI Announces Agreement with Accord Healthcare to Jointly Develop, Manufacture and Commercialize Parenteral Drug Products
AMRI Announces Agreement with Accord Healthcare to Jointly Develop, Manufacture and Commercialize Parenteral Drug Products PR Newswire
21.02.17 - PR Newswire
AMRI Announces Agreement with Accord Healthcare to Jointly Develop, Manufacture and Commercialize Parenteral Drug Products
AMRI Announces Agreement with Accord Healthcare to Jointly Develop, Manufacture and Commercialize Parenteral Drug Products PR Newswire

Newssuche

Videos

newspaper
26.04.24 +6,31%
Technical Trading: Gold Long freitags
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »